Delivery Order SPE2DB22D3004-SPE2DB25FSC08
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 28, 2025, for Menveo A-C-Y-W vaccine kits (2 vials) with a ceiling value of $13,567.88 under firm fixed-price terms. This non-set-aside contract is scheduled for completion by July 29, 2025, with performance taking place at the company's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC SPE2DX)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials) with a ceiling value of $1,342.88. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a routine pharmaceutical procurement supporting the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $1,625.70 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed price delivery order carries a ceiling value of $2,014.32 and is scheduled for completion by August 29, 2025. The contract represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a $2,350.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for a Menveo A-C-Y-W Kit (2 vials) on August 5, 2025, with a completion date of August 6, 2025. This non-set-aside contract represents a routine pharmaceutical procurement through the company's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $2,138.48 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement under the company's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded a $6.38K delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W vaccine kits (2 vials) on September 17, 2025, with completion targeted for September 18, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M and extending through December 2026. The prime IDC serves as a comprehensive...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSC08Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for Menveo A-C-Y-W Kit (2 Vials) with a ceiling value of $1,342.88. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order supports DLA's pharmaceutical supply chain operations and represents part of AmerisourceBergen's extensive portfolio of medical product deliveries to federal healthcare systems. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities through its prime vendor agreements with the Defense Logistics Agency. The Menveo vaccine kit falls within the company's broader capabilities to deliver vaccines and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/21/25 |